The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea

S. L. Padilla, G. K. Person, Paul G McDonough, R. H. Reindollar

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The response to bromocriptine therapy of 12 infertile women with ovulatory dysfunction and euprolactinemic galactorrhea was studied. Four of the subjects had anovulation, four had oligoovulation, and four had delayed ovulation. Serum PRL levels in all 12 subjects were < 20 ng/ml. Normal ovulation occurred at least once in all of the patients on bromocriptine therapy and in 38 of 41 (92%) of the cycles. Seven patients (58%) conceived promptly with bromocriptine therapy, and all subjects had cessation of galactorrhea within 1 month of the onset of therapy. The seven pregnancies included five normal term vaginal deliveries, one premature vaginal delivery, and one tubal pregnancy. The results of this study should be considered preliminary but suggest that the presence of euprolactinemic galactorrhea in patients with ovulatory dysfunction may still represent a covert disorder of PRL physiologic factors. The prompt correction of these ovulation disturbances gives supporting evidence for this hypothesis and suggests that a short trial of bromocriptine therapy may be warranted after minimal blood sampling. The differential outcome between our group of patients produces further evidence that variable mechanisms may be operative.

Original languageEnglish (US)
Pages (from-to)695-698
Number of pages4
JournalFertility and Sterility
Volume44
Issue number5
DOIs
StatePublished - Jan 1 1985

Fingerprint

Galactorrhea
Bromocriptine
Ovulation
Anovulation
Tubal Pregnancy
Therapeutics
Pregnancy
Serum

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea. / Padilla, S. L.; Person, G. K.; McDonough, Paul G; Reindollar, R. H.

In: Fertility and Sterility, Vol. 44, No. 5, 01.01.1985, p. 695-698.

Research output: Contribution to journalArticle

Padilla, S. L. ; Person, G. K. ; McDonough, Paul G ; Reindollar, R. H. / The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea. In: Fertility and Sterility. 1985 ; Vol. 44, No. 5. pp. 695-698.
@article{a76a593ebd544ee2826f472fcee9d54e,
title = "The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea",
abstract = "The response to bromocriptine therapy of 12 infertile women with ovulatory dysfunction and euprolactinemic galactorrhea was studied. Four of the subjects had anovulation, four had oligoovulation, and four had delayed ovulation. Serum PRL levels in all 12 subjects were < 20 ng/ml. Normal ovulation occurred at least once in all of the patients on bromocriptine therapy and in 38 of 41 (92{\%}) of the cycles. Seven patients (58{\%}) conceived promptly with bromocriptine therapy, and all subjects had cessation of galactorrhea within 1 month of the onset of therapy. The seven pregnancies included five normal term vaginal deliveries, one premature vaginal delivery, and one tubal pregnancy. The results of this study should be considered preliminary but suggest that the presence of euprolactinemic galactorrhea in patients with ovulatory dysfunction may still represent a covert disorder of PRL physiologic factors. The prompt correction of these ovulation disturbances gives supporting evidence for this hypothesis and suggests that a short trial of bromocriptine therapy may be warranted after minimal blood sampling. The differential outcome between our group of patients produces further evidence that variable mechanisms may be operative.",
author = "Padilla, {S. L.} and Person, {G. K.} and McDonough, {Paul G} and Reindollar, {R. H.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/S0015-0282(16)48989-2",
language = "English (US)",
volume = "44",
pages = "695--698",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea

AU - Padilla, S. L.

AU - Person, G. K.

AU - McDonough, Paul G

AU - Reindollar, R. H.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The response to bromocriptine therapy of 12 infertile women with ovulatory dysfunction and euprolactinemic galactorrhea was studied. Four of the subjects had anovulation, four had oligoovulation, and four had delayed ovulation. Serum PRL levels in all 12 subjects were < 20 ng/ml. Normal ovulation occurred at least once in all of the patients on bromocriptine therapy and in 38 of 41 (92%) of the cycles. Seven patients (58%) conceived promptly with bromocriptine therapy, and all subjects had cessation of galactorrhea within 1 month of the onset of therapy. The seven pregnancies included five normal term vaginal deliveries, one premature vaginal delivery, and one tubal pregnancy. The results of this study should be considered preliminary but suggest that the presence of euprolactinemic galactorrhea in patients with ovulatory dysfunction may still represent a covert disorder of PRL physiologic factors. The prompt correction of these ovulation disturbances gives supporting evidence for this hypothesis and suggests that a short trial of bromocriptine therapy may be warranted after minimal blood sampling. The differential outcome between our group of patients produces further evidence that variable mechanisms may be operative.

AB - The response to bromocriptine therapy of 12 infertile women with ovulatory dysfunction and euprolactinemic galactorrhea was studied. Four of the subjects had anovulation, four had oligoovulation, and four had delayed ovulation. Serum PRL levels in all 12 subjects were < 20 ng/ml. Normal ovulation occurred at least once in all of the patients on bromocriptine therapy and in 38 of 41 (92%) of the cycles. Seven patients (58%) conceived promptly with bromocriptine therapy, and all subjects had cessation of galactorrhea within 1 month of the onset of therapy. The seven pregnancies included five normal term vaginal deliveries, one premature vaginal delivery, and one tubal pregnancy. The results of this study should be considered preliminary but suggest that the presence of euprolactinemic galactorrhea in patients with ovulatory dysfunction may still represent a covert disorder of PRL physiologic factors. The prompt correction of these ovulation disturbances gives supporting evidence for this hypothesis and suggests that a short trial of bromocriptine therapy may be warranted after minimal blood sampling. The differential outcome between our group of patients produces further evidence that variable mechanisms may be operative.

UR - http://www.scopus.com/inward/record.url?scp=0022373668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022373668&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(16)48989-2

DO - 10.1016/S0015-0282(16)48989-2

M3 - Article

VL - 44

SP - 695

EP - 698

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -